Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1941-9074
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy ; volume:12 ; number:1 ; day:8 ; month:11 ; year:2018 ; pages:1 ; date:1.2019
Current Cardiovascular Imaging Reports ; 12, Heft 1 (8.11.2018), 1, 1.2019
- Urheber
-
Shah, Nishant R.
Blankstein, Ron
Villines, Todd
Imran, Hafiz
Morrison, Alan R.
Cheezum, Michael K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12410-018-9476-y
- URN
-
urn:nbn:de:101:1-2018122723222667124852
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shah, Nishant R.
- Blankstein, Ron
- Villines, Todd
- Imran, Hafiz
- Morrison, Alan R.
- Cheezum, Michael K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
Cardiac allograft vasculopathy in Dutch heart transplant recipients
Post-contrast non-selective double inversion recovery imaging of the coronary arteries in patients with coronary allograft vasculopathy
Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Management of Coronary Artery Calcium and Coronary CTA Findings
Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy
Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
Früherkennung einer "cardiac allograft vasculopathy" nach pädiatrischer Herztransplantation mittels neuer invasiver und nichtinvasiver diagnostischer Verfahren
Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
Cardiac allograft vasculopathy in Dutch heart transplant recipients
Post-contrast non-selective double inversion recovery imaging of the coronary arteries in patients with coronary allograft vasculopathy
Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Management of Coronary Artery Calcium and Coronary CTA Findings
Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy
Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
Früherkennung einer "cardiac allograft vasculopathy" nach pädiatrischer Herztransplantation mittels neuer invasiver und nichtinvasiver diagnostischer Verfahren
Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
Cardiac allograft vasculopathy in Dutch heart transplant recipients
Post-contrast non-selective double inversion recovery imaging of the coronary arteries in patients with coronary allograft vasculopathy
Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Management of Coronary Artery Calcium and Coronary CTA Findings
Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy
Epicardial fat volume is related to the degree of cardiac allograft vasculopathy